Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Awarded Contract from Minnesota to Perform Mass Spec-based Newborn Screening

NEW YORK (GenomeWeb News) – PerkinElmer has won a contract with the Minnesota Department of Health to perform mass spectrometry-based newborn screening.

Under the terms of the contract, PerkinElmer will conduct tandem mass spec testing for 42 of 56 conditions screened for in newborns in the state, a spokesman for the health department told GenomeWeb Daily News. Minnesota had previously contracted with the Mayo Clinic for the services.

Waltham, Mass.-based PerkinElmer also will perform, when necessary, secondary screening for congenital adrenal hyperplasia. The state performs primary screening for the condition.

"If our first test result is abnormal (positive), we ask that PerkinElmer … do a second test to see if it is truly positive before calling it out," the spokesman said.

The contract took effect on Jan. 1, 2014 and originally was to last until May 1, 2014. Last week, the parties extended it until Dec. 31, 2015 with an option for further extension.

Under the terms of the contract, Minnesota will pay PerkinElmer $10 per specimen screened. The state said that it anticipates the company will receive 70,000 screens per year.

PerkinElmer did not respond to requests for comment.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.